首页> 新闻动态> 韩国生物IT代表团来访易特科集团研发中心

韩国生物IT代表团来访易特科集团研发中心

2014-09-26 17:00

      


       2014年9月26日,SH医疗董事会主席朴隆达先生率领韩国生物IT代表团来访位于深圳市高新区南区数字技术园3F和4F的易特科集团生物IT研发中心,与易特科CEO张贯京先生,CTO葛新科博士,总工程师陈兴明先生以及医学科学家进行了深入交流,双方就相关项目和技术合作达成初步意向。SH医疗在尿液检测和监护技术世界领先,拥有强大创新能力。易特科AnyCheck安测移动健康云服务在技术创新方面走到了世界前列,广泛应用循证医学、大数据挖掘、生物物联网、TD LTE互联网、可穿戴终端、LifeTelling健康要素交换、智能交互医学机器人、连锁社区医院管理、网络医院等先进技术,开拓和创新独有的慢病管理慢病干预O2O新技术,取得了200多项美国发明专利、中国发明专利、实用新型专利和欧美技术认证,并获得了国内外合作伙伴和市场的高度认可,目前已经获得300万以上的注册用户,在移动医疗领域独树一帜,受到消费者、媒体和资本界的追捧。


       On September 26th, 2014, Mr Yung dal Park, Chairman of the board of the SH Medical, led the South Korea Bio-IT delegation visited E-Techco Group’s Bio-IT R&D center, which is located in the 3F and 4F of the digital park in Shenzhen Hi-Tech Science Park. The South Korea Bio-IT delegation had a deep discussion with E-Techco’s CEO John Zhang, CTO Dr Mike Ge, Chief Engineer Richard Chen and other medical scientists, the two parties reached initial intent of cooperation. SH Medical has the world leading technologies in urine detection and urine monitor, and have strong innovation ability.

       E-Techco AnyCheck mobile health cloud service innovation rivals the best in the world, widely apply evidence-based medicine, big data mining, bio-IOT, TD LTE network, wearable terminals, LifeTelling health elements exchange platform, smart interaction medical robot, chain community hospital management, network hospital, etc, innovated and developed exclusive chronic diseases intervention O2O new technologies, acquired more than 200 US patents, Chinese patents, utility model patents and the EU, US technical certifications, got cooperators’ and markets’ high recognition and favors at home and abroad, has more than 3 million registration users, develops a school of its own in the mobile medical area, is pursued and admired by the consumers, medias, capitals.


按年份查询

全部

2020

2019

2018

2017

2016

2015

2014

2013

搜索